Separation Systems for Commercial Biotechnology

The global market for commercial biotechnology separation systems reached nearly $16 billion in 2012 and is expected to reach $17.1 billion by the end of 2013. The market is expected to grow at a compound annual growth rate (CAGR) of 10.1%, reaching a value of $27.8 billion by 2018.

Report Includes

• An overview of the global market for the commercial applications of biotechnology separation systems by product, by company, and by geographic region.
• Analyses of global market trends, with data from 2008 to 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
• Examination of the various segments of the market, new applications for separation technology, and overall industry trends, as well as the separation process for a variety of biomolecules, including proteins, RNA, and DNA.
• Identification of one of the major drivers for the separations system market: the development by the biomedical and pharmaceutical industries of proteins that can be used as biotherapeutic agents against a number of human diseases; another factor that will contribute to growth is the recognition of this technology in emerging markets such as Japan and the Pacific Rim countries.
• Assessments of trends based on a number of parameters, including projected sales for existing products, new product introductions, and expanded indications for existing products.

The global market for commercial biotechnology separation systems reached $12.1 billion in 2010, $14.6 billion in 2011, and it will further grow to $26.7 billion at an estimated compound annual growth rate (CAGR) of 12.8% by 2016.

• The U.S. market for protein separation systems is estimated to be valued at almost $3.0 billion in the base year, 2006. This market is expected to grow with an average annual growth rate (AAGR) of 11.1% and cross the $5.0 billion by the year 2011.
• The liquid chromatography market was $944 million in 2004 and will rise to more than $1.1 billion in the year 2006. This market has been showing exceptional growth due to its ability to separate large molecules before major analysis. This market is expected to reach $2.1 billion by 2011, an AAGR of 13.0%.
• The membrane filtration segment is valued at $538 million in year 2006 with an estimated growth of 10.8% and is predicted to grow to $898 million in year 2011. Though the capital costs involved in membrane filtration are higher than chemical treatments, the system increases energy and utilizes less company space as compared to chemical processes. This enables companies to reduce costs by upwards of 65%.

• Biotech separations is a $2.1 billion in the U.S. in 2003 and is projected to rise to $3.6 billion in 2008, at an average annual rate (AAGR) of 11.0%.
• Fast runs, high throughput and reproducibility are factors in liquid chromatography’s dominance. Rising at an AAGR of 11.3%, this segment will increase to $1.69 billion in 2008.
• Competition from membrane technologies should continue to limit growth of centrifugation to an AAGR of 6.0% through 2008
• Readily met sanitary design regulations, easily enclosed systems and greater recovery rates contribute to an AAGR of 14.1% for membrane filtration. Sales should reach $673 million in 2008.
• Electrophoresis systems, led by capillary designs, will rise at an AAGR of 8.3% from $249 million in 2003 to $371 million in 2008.